āHow do you store and dispose of naloxone?
Naloxone storage
- Follow manufacturer instructions for storing naloxone. Storage instructions may be different.
- Keep naloxone in its box until ready for use.
- Protect from light.
- Store at room temperature below 77Ā°F (25Ā°C).
- Do not freeze or expose to heat above 104Ā°F (40Ā°C).
- Store in a safe location.
Learn more about NarcanĀ®ā storage.
Naloxone disposal
Unused naloxone: Dispose of unused naloxone at a local pharmacy or through a medicine
take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. Learn more about safe disposal options.
Used naloxone:
- Nasal spray, such as NarcanĀ®: Put the used naloxone nasal spray back into its box. Dispose of it in solid waste trash.
- Injectable naloxone: Put the used injectable naloxone back into its original container/box. Used injectable naloxone is considered medical waste and must be disposed of in a sharps disposal bin, such as at a local pharmacy. Do not throw away used injectable naloxone in solid waste trash.
Expired naloxone
Expired naloxone is better than no naloxone: If you have expired or soon-to-expire intranasal NarcanĀ® or injectable (intramuscular) naloxone that has been properly stored, contact a local syringe services program about donating the naloxone. If you have a large amount (10+ doses), you can contact NEXT Distro about donating the naloxone.
NarcanĀ®ā nasal spray shelf-life extension: The U.S. Food and Drug Administration (FDA) has approved an extended shelf-life for the nasal spray formulation of naloxone (NarcanĀ®ā [PDF]) from two years (24 months) to three years (36 months).āā
An important part of a naloxone distribution program is to provide training to individuals who may give naloxone. Listed below are training resources.
California laws protect persons who give naloxone and make naloxone more readily available.
A person cannot be liable for any civil damages that result from his or her providing of emergency care, if:
-
The person acted in good faith, and not for compensation;
-
The person provided either emergency medical care or nonmedical care; and
-
The care was provided at the scene of an emergency.
Eliminates civil and criminal liability for:
-
Licensed health care providers that prescribe naloxone and issue standing orders for the distribution of naloxone; and
- Individuals that administer naloxone to someone suspected of experiencing an overdose after receiving it along with required training.āā
The California State Public Health Officer has issued a CDPH statewide standing order to increase access to naloxone. Review the FAQs (PDF) āand terms and conditions to determine if your organization or entity should apply here:
CDPāāH Naloxone Standing Order Application Ā»
California Senate Bill (SB) 833 (Chapter 30, Statutes of 2016) added Part 6.2, Section 1179.80 to the California Health & Safety Code to require the California Department of Public Health (CDPH) to establish the Naloxone Grant Program. The goal of the program was to reduce the number of fatal overdoses in California from opioid drugs, including prescription opioids and heroin, by increasing access to the life-saving drug naloxone. The California Legislature allocated a one-time appropriation of $3 million from the General Fund in the Budget Act of 2016 to support this program through June 30, 2019. See the Naloxone Grant Program Final Report (PDF).
Clinicians
Healthcare Administrators
Pharmacists
Family Members and Caregivers
Sources
NarcanĀ® is a registered trademark of Emergent Operations Ireland Limited.